Dube K, Barr E, Philbin M, Perez-Brumer A, Minalga B, Peterson B
HIV Res Clin Pract. 2023; 24(1):2246717.
PMID: 37608645
PMC: 10454980.
Dube K, Shelton B, Patel H, Ndukwe S, Concha-Garcia S, Dullano C
J Virus Erad. 2023; 9(2):100328.
PMID: 37440872
PMC: 10334343.
DOI: 10.1016/j.jve.2023.100328.
Dube K, Eskaf S, Barr L, Palm D, Hogg E, Simoni J
AIDS Res Hum Retroviruses. 2022; 38(6):510-517.
PMID: 35323030
PMC: 9225827.
DOI: 10.1089/AID.2021.0170.
Dube K, Eskaf S, Hastie E, Agarwal H, Henley L, Roebuck C
J Pers Med. 2022; 12(2).
PMID: 35207719
PMC: 8879991.
DOI: 10.3390/jpm12020231.
Miall A, McLellan R, Dong K, Ndungu T, Saberi P, Sauceda J
J Virus Erad. 2022; 8(1):100062.
PMID: 35169489
PMC: 8829132.
DOI: 10.1016/j.jve.2021.100062.
Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States.
Dube K, Kanazawa J, Dee L, Taylor J, Sauceda J, Gianella S
AIDS Res Ther. 2021; 18(1):75.
PMID: 34663375
PMC: 8522863.
DOI: 10.1186/s12981-021-00401-8.
Ethics of HIV cure research: an unfinished agenda.
Dube K, Kanazawa J, Taylor J, Dee L, Jones N, Roebuck C
BMC Med Ethics. 2021; 22(1):83.
PMID: 34193141
PMC: 8243312.
DOI: 10.1186/s12910-021-00651-1.
Impact of dedicated women's outreach workers (WOWs) on recruitment of women in ACTG clinical studies.
Barr E, Dube K, Swaminathan S, Del Rio C, Campbell D, Paez-Quinde M
HIV Res Clin Pract. 2021; 22(2):37-45.
PMID: 34143949
PMC: 8496343.
DOI: 10.1080/25787489.2021.1938825.
Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
Dube K, Kanazawa J, Campbell C, Boone C, Maragh-Bass A, Campbell D
AIDS Res Hum Retroviruses. 2021; 38(1):50-63.
PMID: 33947268
PMC: 8785755.
DOI: 10.1089/AID.2021.0023.
Time to Engage Young People in HIV Cure Research.
Saberi P, Campbell C, Venegas M, Dube K
AIDS Res Hum Retroviruses. 2021; 38(1):2-4.
PMID: 33677996
PMC: 8785756.
DOI: 10.1089/AID.2020.0268.
Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.
Diepstra K, Barr L, Palm D, Hogg E, Mollan K, Henley L
AIDS Res Hum Retroviruses. 2021; 37(6):489-501.
PMID: 33472545
PMC: 8213012.
DOI: 10.1089/AID.2020.0222.
Framing a Consent Form to Improve Consent Understanding and Determine How This Affects Willingness to Participate in HIV Cure Research: An Experimental Survey Study.
Sauceda J, Dube K, Brown B, Perez A, Rivas C, Evans D
J Empir Res Hum Res Ethics. 2020; 16(1-2):78-87.
PMID: 33307932
PMC: 8035136.
DOI: 10.1177/1556264620981205.
Altruism: Scoping review of the literature and future directions for HIV cure-related research.
Dube K, Perry K, Mathur K, Lo M, Javadi S, Patel H
J Virus Erad. 2020; 6(4):100008.
PMID: 33294210
PMC: 7695811.
DOI: 10.1016/j.jve.2020.100008.
Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology?.
Dube K, Willenberg L, Dee L, Sylla L, Taylor J, Roebuck C
J Virus Erad. 2020; 6(4):100017.
PMID: 33251025
PMC: 7646673.
DOI: 10.1016/j.jve.2020.100017.
Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach.
Peluso M, Dee L, Shao S, Taylor J, Campbell D, Collins S
Clin Infect Dis. 2020; 72(10):1843-1849.
PMID: 32841311
PMC: 7499539.
DOI: 10.1093/cid/ciaa1260.
Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
Dube K, Campbell D, Perry K, Kanazawa J, Saberi P, Sauceda J
AIDS Res Hum Retroviruses. 2020; 36(12):1054-1058.
PMID: 32829645
PMC: 7703233.
DOI: 10.1089/AID.2020.0107.
"My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life.
Perry K, Dube K, Concha-Garcia S, Patel H, Kaytes A, Taylor J
AIDS Res Hum Retroviruses. 2020; 36(12):1071-1082.
PMID: 32449625
PMC: 7703253.
DOI: 10.1089/AID.2020.0020.
Impact of implementing an online interactive educational tool for future HIV "cure" research in an HIV clinic waiting room in Cape Town, South Africa.
Hendricks M, Varathan O, Cassim F, Kidd M, Moodley K
AIDS Care. 2020; 32(8):965-969.
PMID: 32434383
PMC: 7428067.
DOI: 10.1080/09540121.2020.1766661.
Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading.
Dube K, Dee L
J Virus Erad. 2020; 6(2):81-84.
PMID: 32405426
PMC: 7213068.
Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366.
Dube K, Hosey L, Starr K, Barr L, Evans D, Hoffman E
AIDS Res Hum Retroviruses. 2020; 36(4):268-282.
PMID: 32160755
PMC: 7185351.
DOI: 10.1089/AID.2019.0284.
